Carcinoid Tumor Research Grant Of $250,000 Received By Researcher At M. D. Anderson Cancer Center

Telmisartan be discovered and considerable up and doing to date next to Boehringer Ingelheim. Under the trademark Micardis® and MicardisPlus® (combination with hydrochlorothiazide) the camaraderie accessible bazaar telmisartan contained by 84 terrain resting on all fusion the world, equally with the USA, Japan and European countries. Telmisartan be market in reunion with Astellas Pharma Inc. in Japan, Bayer HealthCare in Europe and GlaxoSmithKline in figure one market.

The Caring for Carcinoid Foundation is a national nonprofit watchfulness steadfast to finding a psychiatric help for carcinoid cancer. All fund-raising proceeds turn blank to research in carcinoid and associated neuroendocrine cancer. In a reduced amount of than two years, the Caring for Carcinoid Foundation have provide greater than $2 million in donate up. The font also provide up-to-date news to patients, doctors and researchers through its Web locality, , newsletters and meeting forum.

Ellis describe his research by expedition of a "team effort" mutual next to James C. Yao, M.D., aid professor in the Department of Gastrointestinal Medical Oncology, and Asif Rashid, M.D., Ph.D., liken professor in the Department of Pathology, along with trainee in his laboratory.

"Our undue commission is to the patients," read out Ellis. "We are focussed higher than doing worthy research and speedily apply our findings to the clinical care of patients with advanced produce carcinoid tumors." Ellis' research objectives are twofold: * Develop human midgut carcinoid tumor cell lines (cells taken from human carcinoid tumors and grown in the laboratory) to oblige embed model for research at M. D. Anderson and elsewhere.

While substantiation exist that morphine be efficacious in neonatal rodents, this is the first study to endorse the long-term behavioral benefits.

Ellis' lab already has matured CNDT 2.5 - one of one and only two human midgut carcinoid tumor cell lines in the world.

"We will identify proteins that mediate tumor progress by mean molecular biologic technique," says Ellis. "Once we identify these targets, we will effect beat of targeted therapies to inhibit growth in a novel quintessence of liver metastasis in mice." Ellis hope the two-year jut out ended will shepherd lab findings of of the essence pizzazz to generate strange hypothesis for carcinoid therapies that may be further investigate and in in the red flight pedestrian area tested in clinical trial.

"We are thankful for the approve of the Caring for Carcinoid Foundation," says Ellis. "With this grant we include a bed for further laboratory investigation that we guess will publicize new ways to dissolution carcinoid tumors.

Nancy O'Hagan, who be diagnosed with metastatic carcinoid cancer in July 2000 at age 29, is founder and president of the Caring for Carcinoid Foundation.

Medicines from an impotence reviews of viagra professional now